Tearlab Corp (TEAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2004 | |
| Sales | 960 |
| Cost of Goods | 950 |
| Gross Profit | 10 |
| Operating Expenses | 22,690 |
| Operating Income | -21,730 |
| Other Income | -110 |
| Pre-tax Income | -21,840 |
| Income Tax | -20 |
| Net Income Continuous | -14,799 |
| Net Income | $-21,810 |
| EPS Basic Total Ops | -130.00 |
| EPS Basic Continuous Ops | -88.51 |
| EPS Diluted Total Ops | -130.00 |
| EPS Diluted Continuous Ops | -88.51 |
| EBITDA(a) | $-21,580 |